Stocks
Latest stock market news — earnings, indices, equities, and corporate events explained for retail investors.
1728 articles in Stocks — page 66 of 144
StocksDefense Firm AEVEX Files for IPO on NYSE Under Ticker AVEX
AEVEX, a defense technology contractor, has filed for an IPO to list on the NYSE as AVEX.
StocksNorway Shares Decline as Key Sectors Struggle
Norway's stock market closed lower, driven by losses in media, transport, and financial sectors.
StocksMicrosoft Faces Challenges Amid Internal Reorganization, Analyst Warns
Concerns grow over Microsoft's AI strategy and market position following recent leadership changes.
StocksIsrael's TA 35 Index Sees Modest Gains Amid Sector Strength
Israel's stock market closed higher, driven by gains in insurance and financial sectors, with notable winners and losers.
StocksGreece's Athens General Composite Rises 1.78% Amid Sector Gains
Greek shares closed higher, driven by gains in banking, construction, and travel sectors.
StocksBTIG Downgrades Zimmer Biomet Amid Growth Concerns
BTIG has downgraded Zimmer Biomet, citing weak growth and limited potential for stock gains in the near future.
StocksLockheed Martin Integrates Autonomy in Army's Black Hawk Helicopter
Lockheed Martin's Sikorsky delivers a fully autonomous Black Hawk helicopter to the U.S. Army.
StocksTurkey's BIST 100 Index Rises 0.92% Driven by Technology and Metals
Turkey's stock market closed higher, led by gains in technology and basic metals sectors.
StocksTop Carbon Capture Stocks to Watch Amid Growing AI Infrastructure Demand
As AI spending rises, carbon capture solutions are in demand. Here are key stocks in this sector.
StocksFaraday Future Stock Jumps 26% After SEC Investigation Ends
Faraday Future shares rise after the SEC concludes its investigation without enforcement actions.
StocksMorocco Stock Market Closes Lower; All Shares Remain Unchanged
Morocco's stock market ended lower on Monday, with the All Shares index showing no change.
StocksInsmed Shares Surge on Positive Arikayce Trial Results
Insmed's stock rises 7% after promising trial data for Arikayce, indicating a larger market potential.